Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.
BACKGROUND: Statins inhibit the same biochemical pathway as aminobisphosphonates, therefore these cholesterol-lowering agents may have a beneficial effect on osteoporosis. This possibility has been supported by the finding that some statins also stimulate bone formation, and by observational studies...
Main Authors: | Reid, I, Hague, W, Emberson, J, Baker, J, Tonkin, A, Hunt, D, MacMahon, S, Sharpe, N |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2001
|
Similar Items
-
Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial
by: Reid, I, et al.
Published: (2001) -
Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study.
by: Tonkin, A, et al.
Published: (2000) -
Pravastatin therapy and the risk of stroke.
by: White, H, et al.
Published: (2000) -
Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?
by: Glasziou, P, et al.
Published: (2002) -
Accuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the Long‐term Intervention with Pravastatin in Ischaemic Disease (LIPID) study
by: Dianna Magliano, et al.
Published: (2003-12-01)